PRS Superior to PSA and MRI for Prostate Cancer Screening

Posted: 2025-04-09 21:35:41 UTC

@Eric TopolEricTopol

#cancer

#genetics

#prostatecancer

#PRS

#screening

#NEJM

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Full Thread

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Status

In Progress

VerifiedPartially VerifiedFalse

Last Updated

2025-04-09 21:36:00 UTC

Verified By

Rollup News

A high polygenic risk score (PRS) is more effective than PSA tests or MRI in detecting clinically significant prostate cancer.

PRS outperforms PSA and MRI in prostate cancer screening.

Significant advancement in the utility of PRS for detecting clinically significant prostate cancer (Gleason ≥7).